(Total Views: 376)
Posted On: 03/24/2020 5:23:00 PM
Post# of 36568

Similar partnership and open label trial in lung cancer bodes well for the AE37 approach
https://immuno-oncologynews.com/2020/03/23/io...tic-nsclc/
https://immuno-oncologynews.com/2020/03/23/io...tic-nsclc/

